News & Perspective

Jul 27, 2017

Jul 27, 2017

News Scan for Jul 27, 2017

Saudi MERS case
Public health funding threat
Hepatitis battle snapshot
Global flu vaccine uptake

May 30, 2017

May 30, 2017

News Scan for May 30, 2017

Saudi MERS case
Big chikungunya jump
France ends avian flu pause
Flu vaccine in pregnancy

Aug 16, 2016

Aug 16, 2016

News Scan for Aug 16, 2016

Malaria may boost Ebola survival
Scallop hepatitis A source
Inhaled vs injectable flu vaccine
Camels and human cold virus
Venezuela malaria spike

Dec 09, 2015

Dec 09, 2015

Flu Scan for Dec 09, 2015

Egg allergies and LAIV
More avian flu in France
Avian flu in Taiwan, Germany, Russia

Nov 10, 2015

Nov 10, 2015

News Scan for Nov 10, 2015

More dengue cases in Hawaii
New CSL flu vaccine division

May 27, 2015

May 27, 2015

News Scan for May 27, 2015

Immune response to flu vaccine
Caramel apple Listeria source
Measles, rubella in Europe
Fast drug-resistance test

Oct 27, 2014

Oct 27, 2014

CSL-Novartis deal includes US cell-based flu vaccine plant

The $275 million deal will make the company the second leading player in the $4 billion global flu vaccine market.

Feb 14, 2013

Feb 14, 2013

Euro studies show flu vaccine working best against type B

(CIDRAP News) – New European studies reported today in Eurosurveillance suggest that this year's influenza vaccine is providing good protection against influenza B viruses but only moderate protection against type A—findings more or less consistent with earlier results in the United States.

Nov 21, 2012

Nov 21, 2012

FDA clears first cell-based flu vaccine

(CIDRAP News) – The US Food and Drug Administration (FDA) yesterday approved the nation's first cell-based flu vaccine, a product from Novartis that uses technology that could help vaccinate more Americans in a pandemic but still has many of the same limitations of older egg-based flu vaccines.

Pages

Sort Results

 

Narrow results

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»